Cortexyme Inc.

💊 Neuropharmaceuticals· 📍 San Francisco, CA, USA

Overview

Cortexyme develops small-molecule therapeutics targeting bacterial pathogens linked to Alzheimer's disease neuroinflammation and neurodegeneration.

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Acer Therapeutics

Newton, MA, USA

Praxis Precision Medicine

Cambridge, MA, USA

Axsome Therapeutics

New York, USA

China Performs World's First Commercial BCI Implant, Marking a Pivotal Moment in the Global Brain-Computer Interface Race

2026-07-16 · Industry

NIH Confirms Brain-Computer Device Restores Speech in Human Patient

2026-07-15 · Research

Neurovalens Wins FDA Approval for Wearable PTSD Therapy Aimed at US Veterans

2026-07-14 · Policy

BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets

2026-07-13 · Funding

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Advertise

Newsletter sponsorships, featured listings, and sponsored articles.